Home > Cashflow Statement > INDO US BIOTECH

INDO US BIOTECH
Cashflow Statement

AD     Remove this Ad

INDO US BIOTECH Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹17 Cr₹8.80 Cr₹7.39 Cr₹5.49 Cr₹4.13 Cr
Adjustment ₹3.00 Cr₹2.25 Cr₹2.02 Cr₹1.62 Cr₹1.42 Cr
Changes In working Capital ₹-18 Cr₹-15 Cr₹-8.56 Cr₹-3.81 Cr₹-5.19 Cr
Cash Flow after changes in Working Capital ₹1.77 Cr₹-4.27 Cr₹0.84 Cr₹3.30 Cr₹0.36 Cr
Cash Flow from Operating Activities ₹1.42 Cr₹-4.58 Cr₹0.53 Cr₹2.91 Cr₹0.22 Cr
Cash Flow from Investing Activities ₹-0.79 Cr₹4.28 Cr₹-6.67 Cr₹-5.40 Cr₹-1.75 Cr
Cash Flow from Financing Activities ₹-1.48 Cr₹1.22 Cr₹6.29 Cr₹2.41 Cr₹1.46 Cr
Net Cash Inflow / Outflow ₹-0.85 Cr₹0.91 Cr₹0.14 Cr₹-0.08 Cr₹-0.07 Cr
Opening Cash & Cash Equivalents ₹1.10 Cr₹0.19 Cr₹0.05 Cr₹0.13 Cr₹0.20 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹0.25 Cr₹1.10 Cr₹0.19 Cr₹0.05 Cr₹0.13 Cr

Compare Cashflow Statement of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹253.5 Cr 6.6% 0.6% -41% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,983.7 Cr -0.9% -8.5% -20.8% Stock Analytics
KAVERI SEED COMPANY ₹4,817.8 Cr 14.6% -1.3% -4.4% Stock Analytics
VENKYS (INDIA) ₹2,160.3 Cr 3.7% 3% -9.9% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹935.1 Cr -4.2% -15.7% -36.5% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹409.6 Cr 1.2% -11.1% -5.2% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

6.6%

0.6%

-41%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses